Showing results (1041-1050 of 1,292) with videos related to

Sort By:
Pageof 130
Veterinary and Comparative Oncology|January 26, 2017
Potency and stability of compounded formulations of chlorambucil, melphalan and cyclophosphamideJ H Burton, H K Knych, S D Stanley, et al.
Veterinary and Comparative Oncology|October 26, 2016
Transcriptome analysis of equine sarcoidsE Semik, A Gurgul, T Ząbek, et al.
Veterinary and Comparative Oncology|February 11, 2017
Characteristics of extracellular cyclic AMP-dependent protein kinase as a biomarker of cancer in dogsD H Bhang, U S Choi, B G Kim, et al.
Veterinary and Comparative Oncology|February 15, 2017
Furosemide for prevention of cyclophosphamide-associated sterile haemorrhagic cystitis in dogs receiving metronomic low-dose oral cyclophosphamideL Setyo, M Ma, T Bunn, et al.
Veterinary and Comparative Oncology|October 4, 2016
A literature review of reports of the stability and storage of common injectable chemotherapy agents used in veterinary patientsC M Chan, A E Frimberger, A S Moore
Veterinary and Comparative Oncology|September 2, 2022
The mitotic regulator polo-like kinase 1 as a potential therapeutic target for c-Myc-overexpressing canine osteosarcomasCecilia Gola, Luca Licenziato, Paolo Accornero, et al.
Veterinary and Comparative Oncology|May 3, 2016
Identification of occult micrometastases and isolated tumour cells within regional lymph nodes of previously diagnosed non-metastatic (stage 0) canine carcinomasK M Casey, M A Steffey, V K Affolter
Veterinary and Comparative Oncology|February 24, 2021
Validation of oral brushing as a non-invasive technique for the identification of feline oral squamous cell carcinoma by DNA methylation and TP53 mutation analysisAndrea Renzi, Luca Morandi, Emma Bellei, et al.
Veterinary and Comparative Oncology|February 12, 2021
Genetic variants of BRCA1 and BRCA2 genes in cats with mammary gland carcinomaVerônica Mollica Govoni, Tereza Cristina Da Silva, Juliana Mariotti Guerra, et al.
Veterinary and Comparative Oncology|August 6, 2019
The interaction between RUNX2 and core binding factor beta as a potential therapeutic target in canine osteosarcomaFernando Alegre, Amanda R Ormonde, Dayn R Godinez, et al.
Pageof 130